当前位置： SCI文献检索 > ADVANCES IN THERAPY期刊下所有文献 > Revisiting Existing Evidence of Corneal Endothelial Progenitors and Their Potential Therapeutic Applications in Corneal Endothelial Dysfunction.

Revisiting Existing Evidence of Corneal Endothelial Progenitors and Their Potential Therapeutic Applications in Corneal Endothelial Dysfunction.

Abstract：

PURPOSE:A recent successful clinical trial demonstrated that a less invasive cell-injection procedure is a viable medical modality for treating corneal endothelial dystrophy. This medical advance still relies on human corneal endothelial cell (HCEC) sources derived from rare cornea donations. The progenitor of the corneal endothelium, which has the characteristics of active proliferation and lineage restriction, will be an ideal cell source for expansion ex vivo. However, the distribution of progenitor-like cells in the corneal endothelial sheet has been under debate for more than a decade. METHODS:This paper re-examines the scientific evidence of the existence of human corneal endothelial progenitors (HCEPs) from the aspects of (1) the origin of cornea formation during ocular development, (2) manifestations from clinical studies, and (3) the distinctive properties of ex vivo-cultured subpopulations. RESULTS:The discrepancies regarding different types of progenitor-like cells in various locations of the cornea are based on the fact that the corneal endothelium is derived from different cell types with multiple origins during corneal formation. CONCLUSIONS:Resolving this long-standing issue in corneal biology will enable various types of progenitors to be isolated and their potencies regarding the formation of functional endothelial cells to be examined. Additionally, an effective niche system for quantitatively producing therapeutic cells can be formulated to satisfy the burning need associated with corneal endothelial dystrophy in the future.

journal_name

Adv Ther

journal_title

Advances in therapy

authors

Meir YJ,Chen HC,Chen CC,Ma HD

doi

10.1007/s12325-020-01237-w

subject

Has Abstract

pub_date

2020-03-01 00:00:00

pages

1034-1048

issue

3

eissn

0741-238X

issn

1865-8652

pii

10.1007/s12325-020-01237-w

journal_volume

37

pub_type

杂志文章,评审

相关文献

ADVANCES IN THERAPY文献大全
  • Advances in clinical cardiology.

    abstract：:Multiple, potentially practice-changing cardiology trials have been presented or published over the past year. In this paper, we summarize and place in clinical context, new data regarding management of acute coronary syndrome and ST-elevation myocardial infarction (copeptin assessment, otamixaban, cangrelor, prasugre...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/s12325-014-0141-9

    authors： McNeice AH,McAleavey NM,Menown IB

    更新日期：2014-08-01 00:00:00

  • Nedocromil sodium ophthalmic solution 2% twice daily in patients with allergic conjunctivitis.

    abstract：:In a multicenter, open-label evaluation, 1098 patients with ocular itching and a history of perennial or seasonal allergic conjunctivitis instilled one drop of nedocromil sodium 2% twice daily in each eye. Ocular symptoms, signs, and global improvement were assessed at baseline and 1 month; satisfaction scores, qualit...

    journal_title：Advances in therapy

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1007/BF02850056

    authors： Tauber J,Alocril Community Allergy Trial Study Group.

    更新日期：2002-03-01 00:00:00

  • Meta-Analysis of Regorafenib-Associated Adverse Events and Their Management in Colorectal and Gastrointestinal Stromal Cancers.

    abstract：INTRODUCTION:To assess the risk factors associated with regorafenib-related adverse events (AEs) in metastatic colorectal cancer (mCRC) and gastrointestinal stromal tumors (GIST). We also evaluated different measures of combatting AEs and their success rate to aid physicians in early identification and management of re...

    journal_title：Advances in therapy

    pub_type： 杂志文章,meta分析

    doi：10.1007/s12325-019-01013-5

    authors： Xie G,Gong Y,Wu S,Li C,Yu S,Wang Z,Chen J,Zhao Q,Li J,Liang H

    更新日期：2019-08-01 00:00:00

  • National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US.

    abstract：INTRODUCTION:The Medicare Part D prescription plan has a coverage gap from $2250 to $5100 per year (2006 thresholds) in which patients pay full drug costs (the "donut hole"). We examined prescription costs in patients aged >or=65 years with atrial fibrillation (AF), and the proportions entering/exiting the donut hole i...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-009-0054-1

    authors： Kim MH,Lin J,Kreilick C

    更新日期：2009-08-01 00:00:00

  • Echinacea reduces the risk of recurrent respiratory tract infections and complications: a meta-analysis of randomized controlled trials.

    abstract：INTRODUCTION:Respiratory tract infections are common, and these infections occur frequently in children, susceptible adults, and older persons. The risk for recurrences and complications relates not only to the presence of viruses but also to immune function. Therefore, modulation of the immune system and antiviral int...

    journal_title：Advances in therapy

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s12325-015-0194-4

    authors： Schapowal A,Klein P,Johnston SL

    更新日期：2015-03-01 00:00:00

  • Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis.

    abstract：:This multicenter, double-masked, randomized, parallel-group study compared the efficacy and safety of ketorolac tromethamine 0.5% ophthalmic solution with levocabastine 0.05% and ketorolac tromethamine vehicle in patients with seasonal allergic conjunctivitis. One drop of ketorolac, levocabastine, or vehicle was insti...

    journal_title：Advances in therapy

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：10.1007/BF02854842

    authors： Donshik PC,Pearlman D,Pinnas J,Raizman MB,Tauber J,Tinkelman D,Walters TR

    更新日期：2000-03-01 00:00:00

  • Efficacy and safety of butterbur herbal extract Ze 339 in seasonal allergic rhinitis: postmarketing surveillance study.

    abstract：:The efficacy and safety of the butterbur leaf extract Ze 339 (carbon dioxide extract from the leaves of Petasites hybridus L., 8 mg petasines per tablet) were tested in patients with seasonal allergic rhinitis. In an open postmarketing surveillance study, 580 patients were treated with an average of 2 tablets of Ze 33...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/BF02850143

    authors： Käufeler R,Polasek W,Brattström A,Koetter U

    更新日期：2006-03-01 00:00:00

  • Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.

    abstract：INTRODUCTION:An 8-week trial of amlodipine/valsartan/hydrochlorothiazide (Aml/Val/HCTZ) for moderate or severe hypertension demonstrated more-pronounced blood pressure (BP)-lowering effects compared with dual-component therapies. To elucidate the effects of time and baseline BP on the observed responses, exploratory an...

    journal_title：Advances in therapy

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1007/s12325-009-0077-7

    authors： Calhoun DA,Crikelair NA,Yen J,Glazer RD

    更新日期：2009-11-01 00:00:00

  • Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice--EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study.

    abstract：INTRODUCTION:The aim of this study was to investigate whether the efficacy of liraglutide observed in randomized controlled trials translates into therapeutic benefits in the French population during routine clinical practice. METHODS:This observational, prospective, multicenter study included 3152 adults with type 2 ...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-015-0245-x

    authors： Gautier JF,Martinez L,Penfornis A,Eschwège E,Charpentier G,Huret B,Madani S,Gourdy P

    更新日期：2015-09-01 00:00:00

  • Opioid rotation in clinical practice.

    abstract：INTRODUCTION:Although chronic opioid therapy is usually initiated using short-acting opioids, many patients with chronic pain are subsequently converted to long-acting and extended-release preparations. In clinical practice, optimal management requires careful individualization of dosage in order to achieve an appropri...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/s12325-012-0051-7

    authors： Nalamachu SR

    更新日期：2012-10-01 00:00:00

  • Mental Health Status in Patients Undergoing Intracoronary Acetylcholine Provocation Test.

    abstract：BACKGROUND:Previous studies showed the relation of mental distress such as anxiety and depression to coronary vasoconstriction and myocardial ischemia. However, the mental health status of patients suspected to have vasospastic angina is unclear. METHODS:A total of 99 patients underwent intracoronary acetylcholine (AC...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-020-01424-9

    authors： Saito Y,Shoji T,Tateishi K,Kitahara H,Fujimoto Y,Kobayashi Y

    更新日期：2020-09-01 00:00:00

  • Correction to: Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease.

    abstract：:In the original article. The third author name is incorrect. The correct name is Nicholas J. Leeper. ...

    journal_title：Advances in therapy

    pub_type： 已发布勘误

    doi：10.1007/s12325-020-01220-5

    authors： Berger A,Simpson A,Leeper NJ,Murphy B,Nordstrom B,Ting W,Zhao Q,Berger J

    更新日期：2020-02-01 00:00:00

  • Nonketotic hyperosmolar coma in a patient with type 1 diabetes-related diabetic nephropathy: case report.

    abstract：:Nonketotic hyperosmolar coma (NHC) is characterized by severe hyperglycemia; absence of, or only slight ketosis; nonketotic acidosis; severe dehydration; depressed sensorium or frank coma; and various neurologic signs. This condition is uncommon in type 1 diabetes. Because of little or no osmotic diuresis in patients ...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/BF02849861

    authors： Dogan E,Erkoc R,Sayarlioglu H,Buyukbese A

    更新日期：2005-09-01 00:00:00

  • Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression.

    abstract：:In a randomized, controlled, double-blind trial, 70 patients (mean age, 49.7 years) suffering from mild to moderate depression received one tablet of either St. John's Wort (Hypericum perforatum) extract (Calmigen) or fluoxetine hydrochloride (Prozac) twice a day for 6 weeks. Efficacy was determined according to the 1...

    journal_title：Advances in therapy

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1007/BF02850017

    authors： Behnke K,Jensen GS,Graubaum HJ,Gruenwald J

    更新日期：2002-01-01 00:00:00

  • Short-Term Assessment of Intravitreal Dexamethasone Implant Using Enhanced-Depth Image Optical Coherence Tomography and Optical Coherence Tomography Angiography in Patients with Retinal Vascular Diseases.

    abstract：INTRODUCTION:To evaluate the short-term efficacy and safety of intravitreal dexamethasone implant (IDI) in patients with macular oedema associated with diabetic retinopathy (DR) and retinal vein occlusion (RVO) using enhanced-depth image optical coherence tomography (EDI-OCT) and to estimate the effect of dexamethasone...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-018-0848-0

    authors： Minnella AM,Federici M,Pagliei V,Lanza A,Gambini G,Caputo CG,Falsini B,Caporossi A

    更新日期：2019-02-01 00:00:00

  • Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.

    abstract：INTRODUCTION:Ivabradine has opened up new possibilities for treating stable angina and chronic heart failure by lowering heart rate. Ivabradine lowers heart rate by selectively inhibiting the I f current in the sinoatrial node. This study aimed to determine whether the decrease in heart rate achieved with ivabradine wa...

    journal_title：Advances in therapy

    pub_type： 临床试验,杂志文章

    doi：10.1007/s12325-015-0253-x

    authors： Jedlickova L,Merkovska L,Jackova L,Janicko M,Fedacko J,Novakova B,Chmelarova A,Majernik J,Pella D

    更新日期：2015-10-01 00:00:00

  • Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design.

    abstract：INTRODUCTION:Vitamin E is one of the most promising agents for nonalcoholic steatohepatitis (NASH) treatment, and its drug responsiveness may be closely associated with haptoglobin (Hp) genotype. However, its efficacy and safety remain unknown in China. This clinical trial of vitamin E versus placebo for the treatment ...

    journal_title：Advances in therapy

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1007/s12325-018-0670-8

    authors： Zang S,Chen J,Song Y,Bai L,Chen J,Chi X,He F,Sheng H,Wang J,Xie S,Xie W,Yang Y,Zhang J,Zheng M,Zou Z,Wang B,Shi J,Chinese NAFLD Clinical Research Network (CNAFLD CRN).

    更新日期：2018-02-01 00:00:00

  • Dorsal root ganglion: the target of acupuncture in the treatment of asthma.

    abstract：:Recently, high levels of neurotrophic factors have been found in bronchial asthma; these factors include nerve growth factor, brain-derived neurotrophic factor, and leukemia inhibitory factor, among others. Neurotrophic factors are first synthesized in bronchial epithelial cells, immune cells, and other cells in the a...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/BF02848784

    authors： Feng JT,Hu CP,Li XZ

    更新日期：2007-05-01 00:00:00

  • Pregabalin for alcohol dependence: a critical review of the literature.

    abstract：INTRODUCTION:Alcohol dependence represents a severe pathological disorder associated with a significant rate of morbidity and mortality. To date, limited pharmacological agents exist to treat this disorder, and there is a growing interest for new therapies. In this context, pregabalin represents a promising strategy. P...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-012-0061-5

    authors： Guglielmo R,Martinotti G,Clerici M,Janiri L

    更新日期：2012-11-01 00:00:00

  • Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study.

    abstract：INTRODUCTION:Diabetic peripheral neuropathy (DPN) is one of the most common complications of diabetes and has been associated with cardiovascular disease, the leading cause of mortality in diabetes. As asymptomatic myocardial ischemia (MI) is frequent in diabetes, we hypothesized that DPN may be associated with MI in p...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-016-0399-1

    authors： Baltzis D,Roustit M,Grammatikopoulou MG,Katsaboukas D,Athanasiou V,Iakovou I,Veves A,Manes C,Trakatelli MC

    更新日期：2016-10-01 00:00:00

  • A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma.

    abstract：:This multicenter, randomized, double-blind clinical trial was undertaken to compare the intraocular pressure (IOP)-lowering efficacy and safety of topical bimatoprost 0.03% with that of latanoprost 0.005% for the treatment of patients with normal-tension glaucoma. After washout of all ocular hypotensive medications, p...

    journal_title：Advances in therapy

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1007/BF02850159

    authors： Dirks MS,Noecker RJ,Earl M,Roh S,Silverstein SM,Williams RD

    更新日期：2006-05-01 00:00:00

  • Liraglutide for the treatment of type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials.

    abstract：INTRODUCTION:Liraglutide has been widely used in the treatment of type 2 diabetes mellitus (T2DM), however, the results of a number of randomized placebo-controlled trials on the effects of liraglutide for the treatment of T2DM have varied. The purpose of this study was to assess the effects of liraglutide versus place...

    journal_title：Advances in therapy

    pub_type： 杂志文章,meta分析

    doi：10.1007/s12325-014-0164-2

    authors： Du Q,Wang YJ,Yang S,Zhao YY,Han P

    更新日期：2014-11-01 00:00:00

  • Reduced Hypoglycemia Risk in Type 2 Diabetes Patients Switched to/Initiating Insulin Glargine 300 vs 100 U/ml: A European Real-World Study.

    abstract：INTRODUCTION:Randomized controlled trials and real-world data from the USA have shown similar glycemic control with insulin glargine 300 U/ml (Gla-300) and insulin glargine 100 U/ml (Gla-100) and reduced hypoglycemia risk with Gla-300. This real-world study describes the efficacy and safety of Gla-300 and Gla-100 in pa...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-020-01436-5

    authors： Escalada J,Bonnet F,Wu J,Bonnemaire M,Gupta S,Cambron-Mellott JM,Nicholls C,Müller-Wieland D

    更新日期：2020-09-01 00:00:00

  • Type 2 Diabetes Mellitus Patients' Healthcare Costs Related to Inpatient Hospitalizations: A Retrospective Administrative Claims Database Study.

    abstract：INTRODUCTION:Diabetes-related healthcare costs are increasing in the United States, with inpatient hospitalization the largest component of medical expenditures. The aims of this study were to characterize hospitalized type 2 diabetes mellitus (T2DM) patients, understand the relationship between hospitalization and hea...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-015-0223-3

    authors： Saundankar V,Ellis J,Allen E,DeLuzio T,Moretz C,Meah Y,Suehs B,Bouchard J

    更新日期：2015-07-01 00:00:00

  • Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study.

    abstract：INTRODUCTION:Phase IV post-marketing surveillance studies are needed to evaluate the real-world safety and effectiveness of drug products. This study aimed to evaluate the safety and effectiveness of biosimilar etanercept (Altebrel, AryoGen Co., Iran) in patients with rheumatoid arthritis (RA), ankylosing spondylitis (...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-020-01611-8

    authors： Gharibdoost F,Salari AH,Salesi M,Ebrahimi Chaharom F,Mottaghi P,Hosseini M,Sahebari M,Nazarinia M,Mirfeizi Z,Shakibi M,Moussavi H,Karimifar M,Mowla K,Karimzadeh H,Anjidani N,Jamshidi A

    更新日期：2021-01-11 00:00:00

  • Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase.

    abstract：INTRODUCTION:Increasing dialysate magnesium (D-Mg2+) appears to be an intriguing strategy to obtain cardiovascular benefits in subjects with end-stage kidney disease (ESKD) on hemodialysis. To date, however, hemodialysis guidelines do not suggest to increase D-Mg2+ routinely set at 0.50 mmol/L. METHODS:A randomized 4-...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-020-01505-9

    authors： Del Giorno R,Lavorato Hadjeres S,Stefanelli K,Allegra G,Zapparoli C,Predrag L,Berwert L,Gabutti L

    更新日期：2020-12-01 00:00:00

  • Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sample.

    abstract：OBJECTIVES:Because clinical guidelines do not offer clear recommendations for treatment options after discontinuing a tumor necrosis factor (TNF) blocker, this study evaluated treatment patterns within 360 days after discontinuation of TNF-blocker treatment. METHODS:The IMS LifeLink Health Plan Claims database was use...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-014-0110-3

    authors： Yeaw J,Watson C,Fox KM,Schabert VF,Goodman S,Gandra SR

    更新日期：2014-04-01 00:00:00

  • Effect of epoetin zeta for correction of renal anemia in hemodialysis patients with thalassemia minor.

    abstract：:Two patients with thalassemia minor and end-stage renal failure on hemodialysis were treated with epoetin zeta (Silapo, Retacrit; STADA, Germany), a medicinal product that was developed and registered as biosimilar to epoetin alfa. Dosing was titrated individually for two patients to achieve a stable hemoglobin (Hb) c...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-008-0119-6

    authors： Kumchev E,Koytchev R,Dimitrakov D,Stavrev P,Tsochev G,Siebert-Weigel M

    更新日期：2008-12-01 00:00:00

  • Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis.

    abstract：INTRODUCTION:The European Medicines Agency (EMA) requires vaccine manufacturers to conduct enhanced safety surveillance (ESS) of seasonal influenza vaccines including a near real-time evaluation of collected data. The objective was to identify whether the use of passive surveillance or active surveillance provides diff...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-018-0747-4

    authors： de Lusignan S,Dos Santos G,Byford R,Schuind A,Damaso S,Shende V,McGee C,Yonova I,Ferreira F

    更新日期：2018-08-01 00:00:00

  • Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders.

    abstract：:In an open, controlled study, 44 patients complaining of vertigo, dizziness, or both, caused by vascular vestibular disorders were randomly treated with extract of Ginkgo biloba (EGb 761) 80 mg twice daily or with betahistine dihydrochloride (BI) 16 mg twice daily for 3 months. A complete neuro-otologic and equilibrim...

    journal_title：Advances in therapy

    pub_type： 临床试验,杂志文章

    doi：

    authors： Cesarani A,Meloni F,Alpini D,Barozzi S,Verderio L,Boscani PF

    更新日期：1998-09-01 00:00:00